Effective administration is an essential aspect of every data management platform. Join Logan Smith as he takes questions, walks through everyday use cases, and gives practical tips in administering the core capabilities of the Egnyte for Life Sciences platform.
Ask the Experts. Join an informal live chat hosted by Egnyte's Product Team as they answer any questions you have on the new eTMF solution, existing features and functionality, and future roadmap.
Successful emerging life sciences companies have an early understanding of compliance guidelines, including when to implement GLP, GMP, and GCP workflows, technologies and best practices. Marching too fast can be costly and slow down development; going too slow can result in additional regulatory scrutiny and delays. David Grote, Head of Quality at Immunocore outlines how to identify when to apply compliance principles in the drug development journey, and how to implement GxP guidances, workflows, helpful technologies, and best practices.
With sensitive company data and even more sensitive patient data, life sciences firms are at constant risk of a data breach. Whether the incident is caused by a malicious actor or results from a simple mistake, protecting data needs to be top of mind for every company. Join Robert Kuhn, Director of IT Infrastructure & Security at Travere Therapeutics, and Neil Jones, Cybersecurity Evangelist at Egnyte, as they examine the most pressing cybersecurity threats and outline practical steps to protect your organization.
The data challenges facing nimble biotechs can’t just be solved with more headcount and employing the latest technology. Cutting-edge strategies and tried and true tactics are needed to create modern data infrastructures that can glean insight out of chaos. Join Scott Sacane, Founder and CEO of Catalytic Data Science as he reviews the challenges of modern data management and how we can build processes that are scalable, secure, and compliant.
The ability to take a promising idea to build phase is a long and winding path. Building an operational framework that is scalable and flexible enough for modern biotechs is what allows for hypergrowth. Join this panel of top-tier VCs as they provide insight, trends, and lessons learned for launching successful early-stage companies.
The use of AI in drug discovery has yielded interesting candidates and new ways of "in silico" testing. Join industry expert Brandon Allgood, Chief AI Officer at Valo Health, in a discussion of how innovative biotechs are using AI as a competitive advantage in drug discovery and clinical trials.
Access to quality data is one of the most important accelerators of growth for emerging biotechs. The resulting analysis and insights are enabling a golden age for research and therapy development as modern drug development teams are leveraging technology to unlock scientific data in new ways. Join this discussion to learn about digital workflow automation and the development of NIMBEye, Nimbus’ cloud computing environment that has accelerated the deployment of CRO data from days to minutes.
Scientists can now generate more data in a single day than they could in the preceding decade. Today, translating this deluge of data into actionable insights has become the rate-limiting step to scientific discovery. Researchers struggle to access the computational infrastructure, niche informatics tooling, and data science expertise required to realize the full potential of their experiments. Dr. Mark Kalinich discusses these challenges, reviews the available solutions, and shares how a fully-integrated Bio-IT platform can accelerate scientific discovery and the development of targeted therapeutics and diagnostics.